The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.
New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas.
Vanderbilt researchers describe a new technique for identifying factors that stimulate the proliferation of pancreatic beta cells – factors that might offer therapeutic options for diabetes.
A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.